Microbiota-targeted interventions for elderly-onset rheumatoid arthritis remain an area requiring further investigation

This narrative review explores the potential role of microbiota-targeted interventions in the management of elderly-onset rheumatoid arthritis. The scope of the article includes dietary modifications, nutraceuticals, and fecal microbiota transplantation as potential therapeutic strategies for this specific demographic. The authors discuss the theoretical basis for targeting the microbiome in this context. However, the review does not provide specific numerical data or pooled effect sizes because such details were not reported in the underlying sources. The text acknowledges that adverse events, tolerability, and discontinuation rates were not reported. Furthermore, the review does not specify a comparator group or a defined primary outcome measure. The authors highlight that the current evidence base is incomplete regarding the efficacy of these interventions. Limitations of the available literature are noted, emphasizing the lack of standardized reporting on safety and clinical endpoints. The practice relevance is described as unclear due to the absence of robust data. Clinicians should interpret these findings with caution given the narrative nature of the synthesis and the lack of quantitative evidence.